These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3690986)

  • 21. A three year follow up of patients allocated to placebo, or oral or injectable gold therapy for rheumatoid arthritis.
    Capell HA; Lewis D; Carey J
    Ann Rheum Dis; 1986 Sep; 45(9):705-11. PubMed ID: 3094463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 12-month comparative trial of auranofin and D-penicillamine in rheumatoid arthritis.
    Felix-Davies DD; Stewart AM; Wilkinson BR; Bateman JR; Delamere JP
    Am J Med; 1983 Dec; 75(6A):138-41. PubMed ID: 6419596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of auranofin as demonstrated by improvement in clinical parameters and decrease in anti-inflammatory usage: a long-term, multicenter study.
    Brenol JC; Chahade W; De Freitas GG; De Pádua PM; Rachid A; Samara A; Seda H; Ximenes AC
    Scand J Rheumatol Suppl; 1986; 63():37-45. PubMed ID: 3299682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longterm experience with oral gold in rheumatoid arthritis and psoriatic arthritis.
    Dequeker J; Verdickt W; Gevers G; Vanschoubroek K
    Clin Rheumatol; 1984 Mar; 3 Suppl 1():67-74. PubMed ID: 6432416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loose stools during auranofin treatment: clinical study and some pathogenetic possibilities.
    van Riel PL; Gribnau FW; van de Putte LB; Yap SH
    J Rheumatol; 1983 Apr; 10(2):222-6. PubMed ID: 6408256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A three year comparative study of auranofin and gold sodium thiomalate in rheumatoid arthritis.
    Rau R; Schattenkirchner M; Muller-Fassbender H; Kaik B; Zeidler H; Missler B
    Clin Rheumatol; 1990 Dec; 9(4):461-74. PubMed ID: 2128475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Ann Rheum Dis; 1988 Jul; 47(7):582-7. PubMed ID: 3041924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.
    Borg G; Allander E; Lund B; Berg E; Brodin U; Pettersson H; Trang L
    J Rheumatol; 1988 Dec; 15(12):1747-54. PubMed ID: 14552308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. One-year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate, and placebo.
    Williams HJ; Dahl SL; Ward JR; Karg M; Willkens RF; Meenan RF; Altz-Smith M; Clegg DO; Mikkelsen WM; Kay DR
    Arthritis Rheum; 1988 Jan; 31(1):9-14. PubMed ID: 3125841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Auranofin or D-penicillamine in the treatment of rheumatoid arthritis.
    Hochberg MC
    Ann Intern Med; 1986 Oct; 105(4):528-35. PubMed ID: 3092712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial.
    Bombardier C; Ware J; Russell IJ; Larson M; Chalmers A; Read JL
    Am J Med; 1986 Oct; 81(4):565-78. PubMed ID: 3532786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term therapy with gold salts in rheumatoid arthritis. Review of the literature and personal contribution].
    Copertari N; Cordioli E; Martinelli M
    Minerva Med; 1993 May; 84(5):219-25. PubMed ID: 8316339
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the effects of auranofin and aurothiomalate on laboratory and clinical indicators in patients with rheumatoid arthritis].
    Vlak T; Stambuk B
    Reumatizam; 1998; 46(1):7-19. PubMed ID: 9921004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An open study on the efficacy and safety of auranofin in treating psoriatic arthritis.
    Dequeker J; Gevers G
    Scand J Rheumatol Suppl; 1986; 63():85-95. PubMed ID: 3474779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfasalazine has a better efficacy/toxicity profile than auranofin--evidence from a 5 year prospective, randomized trial.
    McEntegart A; Porter D; Capell HA; Thomson EA
    J Rheumatol; 1996 Nov; 23(11):1887-90. PubMed ID: 8923361
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of appearance of radiological lesions in early rheumatoid arthritis: a randomized, single-blind study comparing intra-articular rifamycin with auranofin.
    Caruso I; Santandrea S; Sarzi Puttini P; Montrone F; Boccassini L; Azzolini V; Cazzola M; Dell'Acqua D
    J Int Med Res; 1992 Feb; 20(1):61-77. PubMed ID: 1568521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term tolerance of oral gold therapy in rheumatoid arthritis. Frequency and intensity of undesirable side effects].
    Goebel KM; Storck U
    Schweiz Med Wochenschr; 1985 Dec; 115(49):1775-7. PubMed ID: 3937234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.